《半日总结》恒指下滑424点 汇控友邦领跌 疫苗股逆市弹
美股三大指数上周五(30日)偏软。港股早市受金融股回吐拖累向下。恒指低开64点後跌幅扩大，最多跌468点一度低见28,256点，半日跌424点或1.48%，报28,300点；国指跌138点或1.28%，报10,686点；恒生科技指数跌108点或1.3%，报8,204点。大市半日成交总额538.47亿元，沪、深港通南下交易继续因内地「五一」长假暂停。
金融股下跌。汇控(00005.HK)跌3.4%报47.2元，拖低恒指81点。友邦(01299.HK)跌2.6%报96.35元，拖低恒指72点。港交所(00388.HK)跌1%报465.2元，渣打(02888.HK)跌2.2%报55.05元。内险股中国太平(00966.HK)、中国平安(02318.HK)及国寿(02628.HK)各跌2.2%至2.4%。内银股建行(00939.HK)及工行(01398.HK)各跌1.3%及1.4%。
科技股造淡，阿里巴巴(09988.HK)跌1%报222.8元，腾讯(00700.HK)跌0.2%报621.5元，美团(03690.HK)跌1.7%报293元，小米(01810.HK)跌0.4%报24.5元，京东(09618.HK)旗下京东物流上市申请获港交所通过，京东股价逆升0.1%报299.2元。百度(09888.HK)跌0.7%报204.4元。
此外，众安在线(06060.HK)跌4.5%，快手(01024.HK)、新东方在线(01797.HK)、携程(09961.HK)及哔哩哔哩(09626.HK)各跌3.2%至3.6%，恒腾(00136.HK)及阿里健康(00241.HK)股价均跌2.5%。手机相关股方面，富智康(02038.HK)跌4.5%，信际(00732.HK)、丘钛(01478.HK)、瑞声(02018.HK)及鸿腾(06088.HK)各跌2.2%至3%。晶片设备股ASM太平洋(00522.HK)跌2.6%。
内需股受压，海尔智家(06690.HK)及猫眼娱乐(01896.HK)各跌6.1%及8%，维他奶(00345.HK)、国美(00493.HK)、蒙牛(02319.HK)、中国飞鹤(06186.HK)及农夫山泉(09633.HK)各跌2.3%至3.4%。澳门博彩股澳博(00880.HK)及美高梅中国(02282.HK)各跌2.7%及3.7%。
医药股方面，疫苗股现炒作，国药(01099.HK)及复星医药(02196.HK)各弹8.9%及9.1%。此外，康哲药业(00867.HK)及威高(01066.HK)各升5.3%及2.9%，绿叶制药(02186.HK)跌3.2%。
资源股方面，大和下调赣锋锂业(01772.HK)目标价，赣锋锂业早市股价跌5%。中国黄金国际(02099.HK)跌3.5%，紫金(02899.HK)、江铜(00358.HK)及洛钼(03993.HK)各跌2.2%至2.7%。环保能源股龙源(00916.HK)跌5.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
